Kyt Dotson / SiliconANGLE:
Terray Therapeutics, which makes use of AI to speed up small-molecule drug growth, raised a $120M Sequence B led by Bedford Ridge Capital and Nvidia’s NVentures — Terray Therapeutics, a biotechnology firm utilizing synthetic intelligence to speed up the event of small-molecule medication …
Add Comment